Goodwin Advises Royalty Pharma on Transactional and Intellectual Property Aspects of Royalty Stream Purchase From AstraZeneca
November 16, 2026
November 16, 2026
BOSTON, Massachusetts, Nov. 16 [Category: BizLaw/Legal] -- Goodwin, a law firm, posted the following news release:
* * *
Goodwin Advises Royalty Pharma on Transactional and Intellectual Property Aspects of Royalty Stream Purchase From AstraZeneca
*
The Life Sciences team advised transactional and intellectual property (IP) aspects of Royalty Pharma's acquisition of a royalty in Zoryve from AstraZeneca for $100 million upfront. Zoryve, mark . . .
* * *
Goodwin Advises Royalty Pharma on Transactional and Intellectual Property Aspects of Royalty Stream Purchase From AstraZeneca
*
The Life Sciences team advised transactional and intellectual property (IP) aspects of Royalty Pharma's acquisition of a royalty in Zoryve from AstraZeneca for $100 million upfront. Zoryve, mark . . .
